OcuNexus Therapeutics' Series A - II Round

OcuNexus Therapeutics raised a round of funding on February 21, 2007.

OcuNexus Therapeutics is a development stage biopharmaceutical company that develops treatments for front- and back-of-the-eye diseases and disorders.…

Articles about OcuNexus Therapeutics' Series A - II Round: